Breast cancer screening rates are declining,according to a recent study by the Centers forDisease Control and Prevention.
Breast cancer screening rates are declining, according to a recent study by the Centers for Disease Control and Prevention.
CDC researchers analyzed mammography screening utilization for each U.S. state and correlated that with the state's respective breast cancer incidence rate. Although they saw a breast cancer incidence rate reduction from 2000 to 2006, investigators also found a slight decline in mammo use in two-thirds of the states during the same period. Findings were published in the February issue of the American Journal of Roentgenology. A commentary by radiologist Dr. Ruth C. Carlos warned that the trend could lead to the erosion of screening services and preventive care.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.